COVID-SEROINDEX
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Sept 2022)
What this means for you
This application is over — abandoned 19 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90089895
- Mark type
- Stylized text
- Filed
- 03 Aug 2020
- Published for opposition
- 21 Dec 2021
- Abandoned
- 19 Sept 2022
- Attorney of record
- Michelle A. Cooke
Goods and services
- Class 001 — Chemicals: Diagnostic agents, preparations and substances other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or medical research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting and analyzing antibodies, enzymes, antigens, diseases, viruses and infections for scientific, laboratory or medical research use; Test kits consisting of diagnostic preparations, reagents, assays, solutions and buffers for clinical or medical laboratory testing and analysis of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Test kits comprised of diagnostic preparations, reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection for scientific or medical research use; Diagnostic preparations for scientific or research purposes related to vaccines in the fields of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Diagnostic assays, media, solutions and buffers for clinical use; Diagnostic agents for carrying out serologic tests for clinical purposes; Diagnostic reagents for serologic tests of infections for clinical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for clinical and research purposes; Diagnostic preparations for clinical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of SARS-CoV-2, COVID-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to SARS-CoV-2 or COVID-19
Owner
- Kantaro Biosciences LLC, New York, NY, US
- Kantaro Biosciences LLC, New York, NY, US
Prosecution history
- 19 Sept 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Sept 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Feb 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Dec 2021 — PUBLISHED FOR OPPOSITION
- 01 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Aug 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Aug 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Aug 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Mar 2021 — NON-FINAL ACTION E-MAILED
- 20 Mar 2021 — NON-FINAL ACTION WRITTEN
- 26 Feb 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Feb 2021 — NON-FINAL ACTION E-MAILED